Literature DB >> 14511958

Genetic immunization by jet injection of targeted pDNA-coated nanoparticles.

Russell J Mumper1, Zhengrong Cui.   

Abstract

Genetic immunization strategies have largely focused on the use of "naked" plasmid DNA or the gene gun. However, there remains a clear need to further improve the efficiency and/or cost of potential DNA vaccines. The theoretical basis of our research is to rationally design genetic immunization methodologies for nanoparticle-based delivery systems of plasmid DNA, perhaps in combination with already commercially available needle-free devices, such as the Biojector 2000. These methodologies may both reduce the dose of pDNA required and enhance the breadth and depth of protective immune responses (i.e., humoral and cellular). The purpose of this article is to provide detailed experimental methods to (1) engineer and characterize pDNA-coated cationic nanoparticles (<100nm) directly from oil-in-water microemulsion precursors and (2) enhance both the breadth and depth of immune responses after immunization of mice with pDNA-coated nanoparticles by different routes of administration, including intradermal, using a needle-free jet injection device.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511958     DOI: 10.1016/s1046-2023(03)00138-5

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

Review 1.  Clinical applications of DNA vaccines: current progress.

Authors:  Bernadette Ferraro; Matthew P Morrow; Natalie A Hutnick; Thomas H Shin; Colleen E Lucke; David B Weiner
Journal:  Clin Infect Dis       Date:  2011-08-01       Impact factor: 9.079

2.  Needle-Free Jet Injectors and Nanosuspensions: Exploring the Potential of an Unexpected Pair.

Authors:  Michele Schlich; Luca Casula; Aurora Musa; Rosa Pireddu; Giulia Pitzanti; Maria Cristina Cardia; Donatella Valenti; Salvatore Marceddu; Anna Maria Fadda; Maria Antonietta De Luca; Chiara Sinico; Francesco Lai
Journal:  Pharmaceutics       Date:  2022-05-19       Impact factor: 6.525

3.  DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial.

Authors:  Barney S Graham; Mary E Enama; Martha C Nason; Ingelise J Gordon; Sheila A Peel; Julie E Ledgerwood; Sarah A Plummer; John R Mascola; Robert T Bailer; Mario Roederer; Richard A Koup; Gary J Nabel
Journal:  PLoS One       Date:  2013-04-08       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.